Exhibit 99.1 Antero Resources Announces Third Quarter 2025 Financial and Operating Results Denver, Colorado, October 29, 2025—Antero Resources Corporation (NYSE: AR) ("Antero Resources," "Antero," or the "Company") today announced its third quarter 2025 financial and operating results. The relevant consolidated financial statements are included in Antero Resources' Quarterly Report on Form 10-Q for the quarter ended September 30, 2025. Highlights: Michael Kennedy, CEO and President of Antero Resources comme ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission file number 0-24531 CoStar Group, Inc. (Exact name of registrant as specified in its charter) Delaware 52-2091509 (State or other jurisdi ...

Denver, Colorado, October 29, 2025—Antero Midstream Corporation (NYSE: AM) ("Antero Midstream" or the "Company") today announced its third quarter 2025 financial and operating results. The relevant unaudited condensed consolidated financial statements are included in Antero Midstream's Quarterly Report on Form 10-Q for the three months ended September 30, 2025. Exhibit 99.1 Antero Midstream Announces Third Quarter 2025 Financial and Operating Results Third Quarter 2025 Highlights: Michael Kennedy, CEO and P ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-39352 Mirion Technologies, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdict ...

FOR IMMEDIATE RELEASE • Net sales of $103.9 million, down 8.5%; Power Solutions grew 4.7%, and Mobile Solutions declined 16.4%. ◦ Proforma net sales down 4.4% after accounting for rationalization of unprofitable business. • Gross margin improved to $17.5 million (16.8% of sales) and adjusted gross margin improved to $19.6 million (18.8% of sales), up from $16.5 million (14.5%) and $18.6 million (16.3%), respectively, due to net sales growth in Power Solutions, and a successful continuous improvement cost-re ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended: September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-36746 PARAMOUNT GROUP, INC. (Exact name of registrant as specified in its charter) Maryland 32-0439307 (State or other jurisdiction ...

Revenue and Profit - Contract revenues for the three months ended September 30, 2025, were $225.1 million, a decrease of $1.6 million or 1% compared to $226.7 million in the prior year period [102]. - Gross profit for the three months ended September 30, 2025, was $29.8 million, an increase of $2.7 million or 10% from $27.1 million in the prior year period, driven by strong project execution and favorable utilization [103]. - Contract revenues for the nine months ended September 30, 2025, were $619 million, an increase of $39.5 million or 7% compared to $579.5 million in the prior year period, primarily due to new awards and higher volume across the business [106]. - Gross profit for the nine months ended September 30, 2025, was $78.6 million, an increase of $17.7 million or 29% from $60.9 million in the prior year period, driven by strong project execution and favorable utilization [107]. - Net income for the three months ended September 30, 2025, was $3.3 million, down from $4.3 million in the prior year period, impacted by increased SG&A expenses and lower revenues [102]. Expenses - Selling, general and administrative (SG&A) expenses increased to $25.1 million for the three months ended September 30, 2025, up $4.3 million or 20.2% from $20.8 million in the prior year period due to increased spending to support business growth [104]. - Interest expense for the three months ended September 30, 2025, was $2.1 million, a decrease from $3.6 million in the prior year period, reflecting improved borrowing costs [102]. Segment Performance - Operating income for the marine segment for the three months ended September 30, 2025, was $11.0 million, an increase of $5.5 million from $5.5 million in the prior year period, attributed to strong project execution [114]. - The concrete segment reported revenues of $82.2 million for the three months ended September 30, 2025, down from $86.7 million in the prior year period, with an operating loss of $5.7 million compared to an operating income of $2.3 million in the prior year [115][116]. - Marine segment revenues increased by $28.1 million, or 7%, to $405.4 million for the nine months ended September 30, 2025, compared to $377.3 million in 2024 [118]. - Operating income for the marine segment improved by $26.8 million to $22.0 million for the nine months ended September 30, 2025, from an operating loss of $4.8 million in 2024 [119]. - Concrete segment revenues rose by $11.4 million, or 6%, to $213.6 million for the nine months ended September 30, 2025, compared to $202.2 million in 2024 [120]. - Operating loss for the concrete segment was $12.4 million for the nine months ended September 30, 2025, a decrease of $19.1 million from an operating income of $6.7 million in 2024 [121]. Backlog and Working Capital - The consolidated backlog as of September 30, 2025, was $679 million, down from $729 million as of December 31, 2024, with the marine segment backlog at $477 million and concrete segment backlog at $202 million [100]. - Working capital decreased to $71.9 million as of September 30, 2025, from $78.2 million at December 31, 2024 [122]. Cash Flow and Capital Expenditures - Cash flows provided by operating activities were $14.3 million for the nine months ended September 30, 2025, compared to a cash outflow of $0.7 million in 2024 [124]. - Capital expenditures for the nine months ended September 30, 2025, were $25.5 million, up from $10.6 million in 2024 [127]. Liquidity and Borrowings - The company had $23.0 million in outstanding borrowings under its Credit Agreement as of September 30, 2025, with a weighted average interest rate of 10.89% [134]. - The company believes it will have adequate liquidity for its operations for at least the next 12 months as of September 30, 2025 [123]. - The company entered into a $103.0 million Credit Agreement with White Oak on May 15, 2023, which includes a $65 million revolving credit line [129].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 1-1169 THE TIMKEN COMPANY (Exact name of registrant as specified in its charter) Ohio 34-0577130 (State or other jurisdiction of incorpora ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2025 or ☐ Transition Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the transition period from __________ to __________ Commission file number: 001-37850 ATOMERA INCORPORATED (Exact name of registrant as specified in its charter) | Delaware ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 000-19125 Ionis Pharmaceuticals, Inc. (Exact name of Registrant as specified in its charter) (State or other jurisdiction ...